Mural Oncology (MURA)
NASDAQ: MURA
· Real-Time Price · USD
2.08
0.28 (15.56%)
At close: Aug 20, 2025, 9:41 AM
15.56% (1D)
| Bid | 2.07 |
| Market Cap | 36.11M |
| Revenue (ttm) | 3.49M |
| Net Income (ttm) | -147.15M |
| EPS (ttm) | -8.58 |
| PE Ratio (ttm) | -0.24 |
| Forward PE | -4.17 |
| Analyst | Buy |
| Ask | 2.09 |
| Volume | 1,763,509 |
| Avg. Volume (20D) | 155,506 |
| Open | 2.06 |
| Previous Close | 1.80 |
| Day's Range | 2.06 - 2.09 |
| 52-Week Range | 0.95 - 4.74 |
| Beta | 3.04 |
About MURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-20.26%
Mural Oncology shares are trading lower after the ...
Unlock content with
Pro Subscription
4 months ago
+133.98%
Mural Oncology shares are trading higher after the company announced plans to explore strategic alternatives and discontinue clinical development of nemvaleukin.
2 weeks ago · fool.com
Mural Oncology (MURA) Q2 Loss Widens 49%Mural Oncology (MURA) Q2 Loss Widens 49%